Keywords
fibromyalgia
Categories
How to Cite
Abstract
Fibromyalgia (FM) is widespread and covers different age groups, most commonly occurring between 20 and 50 years. Patients with rheumatic diseases – osteoarthritis (OA) and systemic lupus erythematosus (SLE), have an accompanying/ secondary FM. The presence of secondary fibromyalgia in SLE and OA has been investigated by various authors and is found in approximately 20% of these patients. The purpose of this clinical trial is to analyze correlations under clinical manifestations of primary vs. secondary FM. The present study is prospective and has been performed at the Clinic of Rheumatology of the University Hospital “St. Ivan Rilski” and “Focus 5” Center, Sofia, for the period September 2013 – September 2017. Eighty-three patients with primary FM, 39 patients with FM + OA, 23 patients with FM + SLE, 27 patients with SLE and 36 healthy subjects were included. The present study analyzed the relationship of clinical manifestations and physical (PCS) and mental component summary (MCS) in patients with primary and secondary fibromyalgia (FM) compared with a control group of healthy volunteers. The obtained results prove that development of pain in FM defines concomitant clinical symptoms. Daily functioning in FM is associated with the presence of Von Zerssen depression score to determine the physical component summary. Impact of FM on daily functioning – social functioning, is associated with the HADS score for depression to determine the mental component summary.References
Reshkova V. Clinical characteristics and neuroendicrine changes in primary and secondary fibromyalgia. 2020; Dissertation DSc, Medical University, Sofia, Bulgaria.
Wolfe F, Clauw DJ, FitzCharles MA et al. DC Meeting: 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria article. Sem Arthr Rheum J. ACR/ARHP Annual Meeting, 2016;46(3).
Williams DA, Kratz AL. Patient-Reported Outcomes and Fibromyalgia. Rheum Dis Clin North Am. 2016 May, 42, 2:317-32. doi: 10.1016/j.rdc.2016.01.009. Epub 2016 Mar 17.
Yilmaz H, Karaca G, Demir Polat H, Akkurt H. Comparison between depression levels of women with knee osteoarthritis, rheumatoid arthritis, and fibromyalgia syndrome: a controlled study. Turk J Phys med rehab 2015, 61, 197-202.
Zigmond AS, Sharp RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983, 67 (6), 361-370
Buckhardt CS, Clark SR, Bennett RM. The Fibromyalgia Impact Questionnaire: Development and validation. Journal of Rheumatology, 1991, 18, 728-734.
Ware JE, Snow KK, Kosinski M, Gandek B. SF-36® Health Survey Manual and Interpretation Guide. Boston, MA: New England Medical Center, The Health Institute, 1993. 8. Weinberg S, Gandhi N, Arora S et al. Body image in lupus: Is it disease activity, physical function, depression, pain, fatigue, sleep, fibromyalgia or stress? Int J Clin Rheumatol, 2018, 13, 250-257.
Marks R. Sleep disturbances, stress, obesity and osteoarthritis. EC orthopedics, 2008, 356-367.
Kofler M, Halder W. Alterations in excitatory and inhibitory brainstem interneuronal circuits in fibromyalgia: Evidence of brainstem dysfunction. Clin Neurophysiol, 2013, 1388.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2024 Valentina Reshkova, Simeon Monov, Rasho Rashkov (Author)